Home > Products > CD3 & CD79B
> Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Triple Body)
Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Triple Body) (CAT#: TRIB-070)
Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD3 antibody are both extended with the scFv fragment from an anti-CD79B antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Chronic lymphocytic leukemia (CLL); Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (Triple Body) (TRIB-070). Click the button below to contact us or submit your feedback about this product.